A Study of Brain Radiotherapy With Lapatinib in HER2+ Breast Cancer

December 22, 2016
Julia White, MD

Julia White, MD, professor of Radiation Oncology, Ohio State University, discusses a phase II study of whole brain radiotherapy with concurrent lapatinib in patients with brain metasteses from HER2-positive breast cancer.